Tandem Diabetes Care Inc (OQ:TNDM)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
See Regulatory Filings on SEC
Company Contact
Address: 11075 Roselle St
SAN DIEGO CA 92121-1204
Tel: N/A
Website: https://www.tandemdiabetes.com
IR: See website
Key People
Kim D. Blickenstaff
Chairman of the Board
John F. Sheridan
President, Chief Executive Officer, Director
Leigh A. Vosseller
Chief Financial Officer, Executive Vice President, Treasurer
Susan M. Morrison
Executive Vice President, Chief Administrative Officer
David B. Berger
Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary
Elizabeth A. Gasser
Executive Vice President - Strategy and Corporate Development
Brian B. Hansen
Chief Commercial Officer, Executive Vice President
Business Overview
Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim X2 Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.
Financial Overview
For the three months ended 31 March 2020, Tandem Diabetes Care Inc revenues increased 48% to $97.9M. Net loss decreased 35% to $14.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects FV Adjustments of Financial Investments decrease of 85% to $1.9M (expense), Interest and other expense decrease from $6K (expense) to $0K.
Employees: 1,043 as of Dec 31, 2019
Reporting Currency: U.S. Dollars
Enterprise value: $5,113M as of Mar 31, 2020
Annual revenue (TTM): $394.24M as of Mar 31, 2020
EBITDA (TTM): -$12.84M as of Mar 31, 2020
Net annual income (TTM): -$16.63M as of Mar 31, 2020
Free cash flow (TTM): $0.50M as of Mar 31, 2020
Net Debt Last Fiscal Year: N/A
Shares outstanding: 60,102,978 as of Apr 21, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization